HemoSonics LLC
32
0
0
26
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
12.5%
4 terminated/withdrawn out of 32 trials
86.7%
+0.1% vs industry average
0%
0 trials in Phase 3/4
8%
2 of 26 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (32)
Quantra QPlus in Pediatric Cardiovascular Procedures
Role: lead
Reference Range Study for the Quantra System With the QPlus Cartridge in Pediatric Patients
Role: lead
QStat Cartridge in Obstetric Patients
Role: lead
Reference Range Study for the Quantra System With the QStat Cartridge in Obstetric Patients
Role: lead
Evaluation of Novel Point of Care Coagulation System in Pregnant Women
Role: collaborator
Quantra® System With the QStat® Cartridge in Trauma
Role: lead
Evaluation of the Quantra QStat System in Obstetric Patients
Role: lead
Quantra QStat Sample Type Comparison
Role: lead
Clinical Evaluation of the Hemosonics Quantra® Coagulation Monitor in Liver and Multivisceral Transplantation
Role: collaborator
Exploratory Assessment of the Quantra® System in Adult ECMO Patients
Role: lead
QPlus Pediatric Reference Interval
Role: lead
Quantra QStat in Trauma and Liver Transplant
Role: lead
Quantra QPlus Sample Type Comparison
Role: lead
Use of the Quantra QPlus Sytem in Cardiac Surgery
Role: lead
Coagulation Changes Associated With COVID-19 Infection
Role: lead
QStat in Liver Transplant
Role: lead
QStat in Trauma and Obstetric Hemorrhage
Role: lead
Evaluation of the Quantra System in a Surgical Oncological Population
Role: lead
QStat Pilot Reference Range Study
Role: lead
Reference Range Study for the Quantra QStat System
Role: lead